BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 21368864)

  • 1. Dietary zinc supplementation of 3xTg-AD mice increases BDNF levels and prevents cognitive deficits as well as mitochondrial dysfunction.
    Corona C; Masciopinto F; Silvestri E; Viscovo AD; Lattanzio R; Sorda RL; Ciavardelli D; Goglia F; Piantelli M; Canzoniero LM; Sensi SL
    Cell Death Dis; 2010 Oct; 1(10):e91. PubMed ID: 21368864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of dietary supplementation of carnosine on mitochondrial dysfunction, amyloid pathology, and cognitive deficits in 3xTg-AD mice.
    Corona C; Frazzini V; Silvestri E; Lattanzio R; La Sorda R; Piantelli M; Canzoniero LM; Ciavardelli D; Rizzarelli E; Sensi SL
    PLoS One; 2011 Mar; 6(3):e17971. PubMed ID: 21423579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyruvate prevents the development of age-dependent cognitive deficits in a mouse model of Alzheimer's disease without reducing amyloid and tau pathology.
    Isopi E; Granzotto A; Corona C; Bomba M; Ciavardelli D; Curcio M; Canzoniero LM; Navarra R; Lattanzio R; Piantelli M; Sensi SL
    Neurobiol Dis; 2015 Sep; 81():214-24. PubMed ID: 25434488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropep-1 ameliorates learning and memory deficits in an Alzheimer's disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques.
    Shin MK; Kim HG; Baek SH; Jung WR; Park DI; Park JS; Jo DG; Kim KL
    Neurobiol Aging; 2014 May; 35(5):990-1001. PubMed ID: 24268884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic knockdown of brain-derived neurotrophic factor in 3xTg-AD mice does not alter Aβ or tau pathology.
    Castello NA; Green KN; LaFerla FM
    PLoS One; 2012; 7(8):e39566. PubMed ID: 22870188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
    Clausen A; Xu X; Bi X; Baudry M
    J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of memory and neuropsychiatric symptoms and reduced tau pathology by selenium in 3xTg-AD mice.
    Van der Jeugd A; Parra-Damas A; Baeta-Corral R; Soto-Faguás CM; Ahmed T; LaFerla FM; Giménez-Llort L; D'Hooge R; Saura CA
    Sci Rep; 2018 Apr; 8(1):6431. PubMed ID: 29691439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrasound with microbubbles improves memory, ameliorates pathology and modulates hippocampal proteomic changes in a triple transgenic mouse model of Alzheimer's disease.
    Shen Y; Hua L; Yeh CK; Shen L; Ying M; Zhang Z; Liu G; Li S; Chen S; Chen X; Yang X
    Theranostics; 2020; 10(25):11794-11819. PubMed ID: 33052247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive-Enhancing Effects of a Polyphenols-Rich Extract from Fruits without Changes in Neuropathology in an Animal Model of Alzheimer's Disease.
    Dal-Pan A; Dudonné S; Bourassa P; Bourdoulous M; Tremblay C; Desjardins Y; Calon F;
    J Alzheimers Dis; 2017; 55(1):115-135. PubMed ID: 27662290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toluidine blue O modifies hippocampal amyloid pathology in a transgenic mouse model of Alzheimer's disease.
    Yuksel M; Biberoglu K; Onder S; Akbulut KG; Tacal O
    Biochimie; 2018 Mar; 146():105-112. PubMed ID: 29248542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ca2+-permeable TRPV1 pain receptor knockout rescues memory deficits and reduces amyloid-β and tau in a mouse model of Alzheimer's disease.
    Kim J; Lee S; Kim J; Ham S; Park JHY; Han S; Jung YK; Shim I; Han JS; Lee KW; Kim J
    Hum Mol Genet; 2020 Jan; 29(2):228-237. PubMed ID: 31814000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal and regional progression of Alzheimer's disease-like pathology in 3xTg-AD mice.
    Belfiore R; Rodin A; Ferreira E; Velazquez R; Branca C; Caccamo A; Oddo S
    Aging Cell; 2019 Feb; 18(1):e12873. PubMed ID: 30488653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tetrahydrobiopterin Improves Recognition Memory in the Triple-Transgenic Mouse Model of Alzheimer's Disease, Without Altering Amyloid-β and Tau Pathologies.
    Fanet H; Tournissac M; Leclerc M; Caron V; Tremblay C; Vancassel S; Calon F
    J Alzheimers Dis; 2021; 79(2):709-727. PubMed ID: 33337360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ibuprofen reduces Abeta, hyperphosphorylated tau and memory deficits in Alzheimer mice.
    McKee AC; Carreras I; Hossain L; Ryu H; Klein WL; Oddo S; LaFerla FM; Jenkins BG; Kowall NW; Dedeoglu A
    Brain Res; 2008 May; 1207():225-36. PubMed ID: 18374906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of HDAC3 reverses Alzheimer's disease-related pathologies in vitro and in the 3xTg-AD mouse model.
    Janczura KJ; Volmar CH; Sartor GC; Rao SJ; Ricciardi NR; Lambert G; Brothers SP; Wahlestedt C
    Proc Natl Acad Sci U S A; 2018 Nov; 115(47):E11148-E11157. PubMed ID: 30397132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Propranolol reduces cognitive deficits, amyloid and tau pathology in Alzheimer's transgenic mice.
    Dobarro M; Gerenu G; Ramírez MJ
    Int J Neuropsychopharmacol; 2013 Nov; 16(10):2245-57. PubMed ID: 23768694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotective Effect of SLM, a Novel Carbazole-Based Fluorophore, on SH-SY5Y Cell Model and 3xTg-AD Mouse Model of Alzheimer's Disease.
    Wu X; Kosaraju J; Zhou W; Tam KY
    ACS Chem Neurosci; 2017 Mar; 8(3):676-685. PubMed ID: 28032988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S14G-humanin improves cognitive deficits and reduces amyloid pathology in the middle-aged APPswe/PS1dE9 mice.
    Zhang W; Zhang W; Li Z; Hao J; Zhang Z; Liu L; Mao N; Miao J; Zhang L
    Pharmacol Biochem Behav; 2012 Jan; 100(3):361-9. PubMed ID: 21993310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disease modifying effect of chronic oral treatment with a neurotrophic peptidergic compound in a triple transgenic mouse model of Alzheimer's disease.
    Kazim SF; Blanchard J; Dai CL; Tung YC; LaFerla FM; Iqbal IG; Iqbal K
    Neurobiol Dis; 2014 Nov; 71():110-30. PubMed ID: 25046994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Both Amyloid-β Peptide and Tau Protein Are Affected by an Anti-Amyloid-β Antibody Fragment in Elderly 3xTg-AD Mice.
    Roda AR; Montoliu-Gaya L; Serra-Mir G; Villegas S
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32927795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.